Market Chats About What Really Went Down with HPSP This Morning

355 Views16 Apr 2024 12:40
​Maekyung's report on HPSP (403870 KS) still signals Crescendo PE's potential stake sale despite the company's outright denial, with timing uncertain but market reactions to be monitored closely.
What is covered in the Full Insight:
  • The Disclosure of Controlling Stake Sale
  • Impact on HPSP's Stock Price
  • Denial of the Report by HPSP
  • Implications of the Six-month Restriction
  • Alternatives and Market Reaction
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
(Paid Plans Only)
Top 5%
Sanghyun Park
Korea / Special Sits, Pairs, Index Rebalancing
Clepsydra Capital
South KoreaEvent-DrivenEquity Bottom-Up
Price Chart(Sign Up to Access)
  • Market Chats About What Really Went Down with HPSP This Morning
    16 Apr 2024